{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:00:04Z","timestamp":1783033204554,"version":"3.54.6"},"reference-count":147,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Overdiagnosis refers to detection of disease that would not otherwise become clinically apparent during a patient\u2019s lifetime. Overdiagnosis is common and has been reported for several cancer types, although there are few studies describing its prevalence in HCC surveillance programs. Overdiagnosis can have serious negative consequences including overtreatment and associated complications, financial toxicity, and psychological harms related to being labeled with a cancer diagnosis. Overdiagnosis can occur for several different reasons including inaccurate diagnostic criteria, detection of premalignant or very early malignant lesions, detection of indolent tumors, and competing risks of mortality. The risk of overdiagnosis is partly mitigated, albeit not eliminated, by several guideline recommendations, including definitions for the at\u2010risk population in whom surveillance should be performed, surveillance modalities, surveillance interval, recall procedures, and HCC diagnostic criteria. Continued research is needed to further characterize the burden and trends of overdiagnosis as well as identify strategies to reduce overdiagnosis in the future.<\/jats:p>","DOI":"10.1002\/hep.32284","type":"journal-article","created":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T12:14:30Z","timestamp":1639916070000},"page":"740-753","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":46,"title":["Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?"],"prefix":"10.1097","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2740-8818","authenticated-orcid":false,"given":"Nicole E.","family":"Rich","sequence":"first","affiliation":[{"name":"Division of Digestive and Liver Diseases,UT Southwestern Medical Center,Dallas,Texas,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1172-3971","authenticated-orcid":false,"given":"Amit G.","family":"Singal","sequence":"additional","affiliation":[{"name":"Division of Digestive and Liver Diseases,UT Southwestern Medical Center,Dallas,Texas,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"issue":"3","key":"hep32284-bib-0001-20250824","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"hep32284-bib-0002-20250824","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","article-title":"Contemporary epidemiology of chronic liver disease and cirrhosis","volume":"18","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"hep32284-bib-0003-20250824","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","year":"1999","journal-title":"Semin Liver Dis"},{"issue":"2","key":"hep32284-bib-0004-20250824","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cgh.2016.07.033","article-title":"Natural history of untreated hepatocellular carcinoma in a US cohort and the role of cancer surveillance","volume":"15","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"hep32284-bib-0005-20250824","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"issue":"2","key":"hep32284-bib-0006-20250824","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"hep32284-bib-0007-20250824","first-page":"565","article-title":"The harms of screening: new attention to an old concern","volume":"307","year":"2012","journal-title":"JAMA"},{"issue":"4","key":"hep32284-bib-0008-20250824","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/hep.28895","article-title":"An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis","volume":"65","year":"2017","journal-title":"Hepatology"},{"issue":"7","key":"hep32284-bib-0009-20250824","first-page":"417","article-title":"Randomized controlled trial of screening for hepatocellular carcinoma","volume":"130","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"hep32284-bib-0010-20250824","article-title":"Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta\u2010analysis","volume":"11","year":"2014","journal-title":"PLoS Medicine"},{"issue":"12","key":"hep32284-bib-0011-20250824","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/hepr.12672","article-title":"Length time bias in surveillance for hepatocellular carcinoma and how to avoid it","volume":"46","year":"2016","journal-title":"Hepatol Res"},{"issue":"2","key":"hep32284-bib-0012-20250824","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jhep.2014.03.037","article-title":"Estimation of lead\u2010time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma","volume":"61","year":"2014","journal-title":"J Hepatol"},{"issue":"5","key":"hep32284-bib-0013-20250824","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.cgh.2018.10.031","article-title":"Hepatocellular carcinoma screening is associated with increased survival of patients with cirrhosis","volume":"17","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep32284-bib-0014-20250824","article-title":"Quantification of harms in cancer screening trials: literature review","volume":"347","year":"2013","journal-title":"BMJ"},{"issue":"2","key":"hep32284-bib-0015-20250824","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jamainternmed.2013.12745","article-title":"The harms of screening: a proposed taxonomy and application to lung cancer screening","volume":"174","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"4","key":"hep32284-bib-0016-20250824","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11901-019-00488-8","article-title":"Harms of hepatocellular carcinoma surveillance","volume":"18","year":"2019","journal-title":"Curr Hepatol Rep"},{"issue":"10","key":"hep32284-bib-0017-20250824","first-page":"1642","article-title":"Cost\u2010effectiveness of hepatocellular carcinoma surveillance: an assessment of benefits and harms","volume":"115","year":"2020","journal-title":"Off J Am College Gastroenterol|ACG"},{"issue":"9","key":"hep32284-bib-0018-20250824","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.cgh.2020.09.014","article-title":"Benefits and harms of hepatocellular carcinoma surveillance in a prospective cohort of patients with cirrhosis","volume":"19","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"hep32284-bib-0019-20250824","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/hep.29315","article-title":"Modeling the benefits and harms of surveillance for hepatocellular carcinoma: information to support informed choices","volume":"66","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"hep32284-bib-0020-20250824","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.291.1.71","article-title":"Enthusiasm for cancer screening in the United States","volume":"291","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"hep32284-bib-0021-20250824","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cgh.2021.02.024","article-title":"Patient preferences for hepatocellular carcinoma surveillance parameters","volume":"20","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"hep32284-bib-0022-20250824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/ebmed-2017-110886","article-title":"Overdiagnosis: what it is and what it isn\u2019t","volume":"23","year":"2018","journal-title":"BMJ Evid Based Med"},{"issue":"16","key":"hep32284-bib-0023-20250824","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/jnci\/92.16.1280","article-title":"Overdiagnosis: an underrecognized cause of confusion and harm in cancer screening","volume":"92","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"hep32284-bib-0024-20250824","article-title":"Preventing overdiagnosis: how to stop harming the healthy","volume":"344","year":"2012","journal-title":"BMJ"},{"issue":"4","key":"hep32284-bib-0025-20250824","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1055\/s-0037-1608775","article-title":"Overdiagnosis: an understudied issue in hepatocellular carcinoma surveillance","volume":"37","year":"2017","journal-title":"Semin Liver Dis"},{"key":"hep32284-bib-0026-20250824","article-title":"Overdiagnosis in primary care: framing the problem and finding solutions","volume":"362","year":"2018","journal-title":"BMJ"},{"issue":"6","key":"hep32284-bib-0027-20250824","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1016\/S1470-2045(13)70598-9","article-title":"Addressing overdiagnosis and overtreatment in cancer: a prescription for change","volume":"15","year":"2014","journal-title":"Lancet Oncol"},{"issue":"15","key":"hep32284-bib-0028-20250824","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJMoa1600249","article-title":"Breast\u2010cancer tumor size, overdiagnosis, and mammography screening effectiveness","volume":"375","year":"2016","journal-title":"N Engl J Med"},{"issue":"13","key":"hep32284-bib-0029-20250824","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jnci\/94.13.981","article-title":"Overdiagnosis due to prostate\u2010specific antigen screening: lessons from US prostate cancer incidence trends","volume":"94","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"hep32284-bib-0030-20250824","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jamainternmed.2013.12738","article-title":"Overdiagnosis in low\u2010dose computed tomography screening for lung cancer","volume":"174","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"4","key":"hep32284-bib-0031-20250824","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.cgh.2014.08.036","article-title":"Prevention, early detection, and overdiagnosis of colorectal cancer within 10 years of screening colonoscopy in Germany","volume":"13","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep32284-bib-0032-20250824","article-title":"Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods","volume":"350","year":"2015","journal-title":"BMJ"},{"issue":"6","key":"hep32284-bib-0033-20250824","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41568-019-0142-8","article-title":"Cancer overdiagnosis: a biological challenge and clinical dilemma","volume":"19","year":"2019","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"hep32284-bib-0034-20250824","article-title":"A reality check for overdiagnosis estimates associated with breast cancer screening","volume":"106","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"hep32284-bib-0035-20250824","doi-asserted-by":"crossref","first-page":"831","DOI":"10.7326\/0003-4819-158-11-201306040-00008","article-title":"Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening","volume":"158","year":"2013","journal-title":"Ann Intern Med"},{"key":"hep32284-bib-0036-20250824","article-title":"Twenty five year follow\u2010up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial","volume":"348","year":"2014","journal-title":"BMJ"},{"issue":"6","key":"hep32284-bib-0037-20250824","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.eururo.2013.12.062","article-title":"Overdiagnosis and overtreatment of prostate cancer","volume":"65","year":"2014","journal-title":"Eur Urol"},{"issue":"19","key":"hep32284-bib-0038-20250824","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/jnci\/djp278","article-title":"Prostate cancer diagnosis and treatment after the introduction of prostate\u2010specific antigen screening: 1986\u20132005","volume":"101","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"hep32284-bib-0039-20250824","first-page":"153","article-title":"The financial burden and distress of patients with cancer: understanding and stepping\u2010up action on the financial toxicity of cancer treatment","volume":"68","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"hep32284-bib-0040-20250824","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/jso.25374","article-title":"Financial toxicity in cancer care: prevalence, causes, consequences, and reduction strategies","volume":"120","year":"2019","journal-title":"J Surg Oncol"},{"key":"hep32284-bib-0041-20250824","doi-asserted-by":"crossref","first-page":"100269","DOI":"10.1016\/j.eclinm.2020.100269","article-title":"Financial toxicity of cancer treatment: moving the discussion from acknowledgement of the problem to identifying solutions","volume":"20","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"2","key":"hep32284-bib-0042-20250824","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jnci\/djq495","article-title":"Projections of the cost of cancer care in the United States: 2010\u20132020","volume":"103","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"hep32284-bib-0043-20250824","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1503\/cmaj.1031205","article-title":"Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers","volume":"170","year":"2004","journal-title":"CMAJ"},{"issue":"9","key":"hep32284-bib-0044-20250824","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jnci\/djq099","article-title":"Overdiagnosis in cancer","volume":"102","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"hep32284-bib-0045-20250824","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1148\/radiol.2017162756","article-title":"Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: systematic review of randomized controlled trials with meta\u2010analysis and trial sequential analysis","volume":"287","year":"2018","journal-title":"Radiology"},{"key":"hep32284-bib-0046-20250824","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1148\/rg.25si055505","article-title":"Complications of percutaneous radiofrequency ablation for hepato\u2010cellular carcinoma: imaging spectrum and management","volume":"25","year":"2005","journal-title":"Radiographics"},{"issue":"1","key":"hep32284-bib-0047-20250824","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/bjs.6358","article-title":"Impact of postoperative complications on long\u2010term outcome of curative resection for hepatocellular carcinoma","volume":"96","year":"2009","journal-title":"Br J Surg"},{"issue":"2","key":"hep32284-bib-0048-20250824","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cgh.2010.09.017","article-title":"CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis","volume":"9","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"hep32284-bib-0049-20250824","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/jamaoncol.2016.3147","article-title":"MRI with liver\u2010specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma","volume":"3","year":"2017","journal-title":"JAMA Oncol"},{"issue":"6","key":"hep32284-bib-0050-20250824","first-page":"e127","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"hep32284-bib-0051-20250824","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/M16-1785","article-title":"Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians","volume":"166","year":"2017","journal-title":"Ann Intern Med"},{"issue":"12","key":"hep32284-bib-0052-20250824","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/S0959-8049(03)00260-0","article-title":"Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening","volume":"39","year":"2003","journal-title":"Eur J Cancer"},{"issue":"4","key":"hep32284-bib-0053-20250824","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","article-title":"Ductal carcinoma in situ: to treat or not to treat, that is the question","volume":"121","year":"2019","journal-title":"Br J Cancer"},{"issue":"2","key":"hep32284-bib-0054-20250824","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","year":"2018","journal-title":"Hepatology"},{"key":"hep32284-bib-0055-20250824","first-page":"55","article-title":"Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response","volume":"6","year":"2020","journal-title":"Hepatoma Res"},{"issue":"11","key":"hep32284-bib-0056-20250824","article-title":"Misdiagnosis of hepatocellular carcinoma in patients receiving no local\u2010regional therapy prior to liver transplant: an analysis of the Organ Procurement and Transplantation Network explant pathology form","volume":"31","year":"2017","journal-title":"Clin Transplant"},{"issue":"40","key":"hep32284-bib-0057-20250824","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.3748\/wjg.v25.i40.6041","article-title":"Role of liver biopsy in hepatocellular carcinoma","volume":"25","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"3","key":"hep32284-bib-0058-20250824","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.27304","article-title":"LI\u2010RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI\u2010RADS Management Working Group and future directions","volume":"61","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"hep32284-bib-0059-20250824","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2018.11.020","article-title":"Accuracy of the liver imaging reporting and data system in computed tomography and magnetic resonance image analysis of hepatocellular carcinoma or overall malignancy\u2010a systematic review","volume":"156","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"hep32284-bib-0060-20250824","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0284185117716700","article-title":"Accuracy of the diagnostic evaluation of hepatocellular carcinoma with LI\u2010RADS","volume":"59","year":"2018","journal-title":"Acta Radiol"},{"issue":"901","key":"hep32284-bib-0061-20250824","first-page":"901.e1","article-title":"Diagnostic efficacy of the Liver Imaging\u2010Reporting and Data System (LI\u2010RADS) with CT imaging in categorising small nodules (10\u201320 mm) detected in the cirrhotic liver at screening ultrasound","volume":"72","year":"2017","journal-title":"Clin Radiol"},{"issue":"3","key":"hep32284-bib-0062-20250824","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/lt.20357","article-title":"Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially\u2010enhancing liver mass","volume":"11","year":"2005","journal-title":"Liver Transpl"},{"issue":"1","key":"hep32284-bib-0063-20250824","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/hep.29487","article-title":"Imaging for the diagnosis of hepatocellular carcinoma: a systematic review and meta\u2010analysis","volume":"67","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"hep32284-bib-0064-20250824","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00261-017-1196-2","article-title":"LI\u2010RADS M (LR\u2010M): definite or probable malignancy, not specific for hepatocellular carcinoma","volume":"43","year":"2018","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"hep32284-bib-0065-20250824","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1148\/radiol.2017170376","article-title":"Interreader reliability of LI\u2010RADS version 2014 algorithm and imaging features for diagnosis of hepatocellular carcinoma: a large international multireader study","volume":"286","year":"2018","journal-title":"Radiology"},{"issue":"1","key":"hep32284-bib-0066-20250824","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00261-019-02133-w","article-title":"Prevalence and clinical significance of discordant LI\u2010RADS\u00ae observations on multiphase contrast\u2010enhanced MRI in patients with cirrhosis","volume":"45","year":"2020","journal-title":"Abdom Radiol (NY)"},{"issue":"5","key":"hep32284-bib-0067-20250824","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1007\/s00330-017-5188-y","article-title":"Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI\u2010RADS) in gadoxetate\u2010enhanced MRI","volume":"28","year":"2018","journal-title":"Eur Radiol"},{"issue":"1018","key":"hep32284-bib-0068-20250824","doi-asserted-by":"crossref","first-page":"e837","DOI":"10.1259\/bjr\/13212920","article-title":"Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid\u2010enhanced MRI","volume":"85","year":"2012","journal-title":"Br J Radiol"},{"issue":"2","key":"hep32284-bib-0069-20250824","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1148\/radiol.10091388","article-title":"Added value of gadoxetic acid\u2013enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma","volume":"255","year":"2010","journal-title":"Radiology"},{"issue":"2","key":"hep32284-bib-0070-20250824","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/dji024","article-title":"The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence","volume":"97","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"hep32284-bib-0071-20250824","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/ajg.2010.122","article-title":"Prevalence of incidental pancreatic cysts in the adult population on MR imaging","volume":"105","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"hep32284-bib-0072-20250824","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/modpathol.2015.2","article-title":"Overdiagnosis of high\u2010grade dysplasia in Barrett\u2019s esophagus: a multicenter, international study","volume":"28","year":"2015","journal-title":"Mod Pathol"},{"issue":"3","key":"hep32284-bib-0073-20250824","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.gastro.2018.07.037","article-title":"Overdiagnosis in colorectal cancer screening: time to acknowledge a blind spot","volume":"155","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"hep32284-bib-0074-20250824","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/lt.25398","article-title":"Frequency and outcomes of abnormal imaging in patients with cirrhosis enrolled in a hepatocellular carcinoma surveillance program","volume":"25","year":"2019","journal-title":"Liver Transpl"},{"issue":"1","key":"hep32284-bib-0075-20250824","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1148\/radiol.2016152173","article-title":"Imaging outcomes of liver imaging reporting and data system version 2014 category 2, 3, and 4 observations detected at CT and MR imaging","volume":"281","year":"2016","journal-title":"Radiology"},{"issue":"6","key":"hep32284-bib-0076-20250824","doi-asserted-by":"crossref","first-page":"S\u2010759","DOI":"10.1016\/S0016-5085(21)02527-0","article-title":"16 risk of progression to hepatocellular carcinoma in patients with indeterminate (li\u2010rads 3) observations","volume":"160","year":"2021","journal-title":"Gastroenterology"},{"issue":"4","key":"hep32284-bib-0077-20250824","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jamcollsurg.2016.12.031","article-title":"Are the current guidelines for the surgical management of intraductal papillary mucinous neoplasms of the pancreas adequate? A multi\u2010institutional study","volume":"224","year":"2017","journal-title":"J Am Coll Surg"},{"issue":"4","key":"hep32284-bib-0078-20250824","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00043426-199211000-00007","article-title":"Past and future of neuroblastoma screening in Japan","volume":"14","year":"1992","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"14","key":"hep32284-bib-0079-20250824","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/jnci\/djt151","article-title":"Prevalence of prostate cancer on autopsy: cross\u2010sectional study on unscreened Caucasian and Asian men","volume":"105","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"hep32284-bib-0080-20250824","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1113162","article-title":"Radical prostatectomy versus observation for localized prostate cancer","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"issue":"18","key":"hep32284-bib-0081-20250824","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US preventive services task force recommendation statement","volume":"319","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"hep32284-bib-0082-20250824","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1023\/A:1022505203786","article-title":"Growth rate of primary single hepatocellular carcinoma: determining optimal screening interval with contrast enhanced computed tomography","volume":"48","year":"2003","journal-title":"Dig Dis Sci"},{"issue":"4","key":"hep32284-bib-0083-20250824","first-page":"311","article-title":"Follow\u2010up examination schedule of postoperative HCC patients based on tumor volume doubling time","volume":"40","year":"1993","journal-title":"Hepatogastroenterology"},{"issue":"5","key":"hep32284-bib-0084-20250824","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/hep.31159","article-title":"Hepatocellular carcinoma demonstrates heterogeneous growth patterns in a multicenter cohort of patients with cirrhosis","volume":"72","year":"2020","journal-title":"Hepatology"},{"issue":"2","key":"hep32284-bib-0085-20250824","first-page":"401","article-title":"Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta\u2010analysis","volume":"70","year":"2021","journal-title":"Gut"},{"issue":"17","key":"hep32284-bib-0086-20250824","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM199304293281706","article-title":"Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy","volume":"328","year":"1993","journal-title":"N Engl J Med"},{"issue":"2","key":"hep32284-bib-0087-20250824","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1378\/chest.96.2.291","article-title":"More lung cancer but better survival. Implications of secular trends in \u201cnecropsy surprise\u201d rates","volume":"96","year":"1989","journal-title":"Chest"},{"issue":"30","key":"hep32284-bib-0088-20250824","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1200\/JCO.2016.67.7419","article-title":"Prevalence of differentiated thyroid cancer in autopsy studies over six decades: a meta\u2010analysis","volume":"34","year":"2016","journal-title":"J Clin Oncol"},{"issue":"7","key":"hep32284-bib-0089-20250824","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/ijc.29538","article-title":"Prevalence of incidental prostate cancer: a systematic review of autopsy studies","volume":"137","year":"2015","journal-title":"Int J Cancer"},{"issue":"6","key":"hep32284-bib-0090-20250824","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000446245","article-title":"Clinicopathological features and metastatic pattern of hepatocellular carcinoma: an autopsy study of 398 patients","volume":"83","year":"2016","journal-title":"Pathobiology"},{"issue":"4","key":"hep32284-bib-0091-20250824","first-page":"334","article-title":"Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in south India\u2013an autopsy study","volume":"33","year":"1990","journal-title":"Indian J Pathol Microbiol"},{"issue":"7455","key":"hep32284-bib-0092-20250824","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/bmj.38142.554479.AE","article-title":"Mortality in relation to smoking: 50 years' observations on male British doctors","volume":"328","year":"2004","journal-title":"BMJ"},{"issue":"5","key":"hep32284-bib-0093-20250824","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung\u2010cancer mortality with low\u2010dose computed tomographic screening","volume":"365","year":"2011","journal-title":"N Engl J Med"},{"key":"hep32284-bib-0094-20250824","article-title":"Mapping the drivers of overdiagnosis to potential solutions","volume":"358","year":"2017","journal-title":"BMJ"},{"key":"hep32284-bib-0095-20250824","article-title":"Intolerance of error and culture of blame drive medical excess","volume":"349","year":"2014","journal-title":"BMJ"},{"issue":"10","key":"hep32284-bib-0096-20250824","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM199109053251002","article-title":"Hepatocellular carcinoma in Italian patients with cirrhosis","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"issue":"1","key":"hep32284-bib-0097-20250824","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2015.07.019","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease","volume":"14","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"03","key":"hep32284-bib-0098-20250824","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","year":"1999","journal-title":"Semin Liver Dis"},{"issue":"3","key":"hep32284-bib-0099-20250824","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","article-title":"Clinical states of cirrhosis and competing risks","volume":"68","year":"2018","journal-title":"J Hepatol"},{"key":"hep32284-bib-0100-20250824","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jhep.2021.01.018","article-title":"New clinical and pathophysiological perspectives defining the trajectory of cirrhosis","volume":"75","year":"2021","journal-title":"J Hepatol"},{"issue":"5","key":"hep32284-bib-0101-20250824","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2019.07.040","article-title":"Direct\u2010acting antiviral therapy for hepatitis C virus infection is associated with increased survival in patients with a history of hepatocellular carcinoma","volume":"157","year":"2019","journal-title":"Gastroenterology"},{"issue":"6","key":"hep32284-bib-0102-20250824","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/cld.1082","article-title":"Direct\u2010acting antiviral therapy and hepatocellular carcinoma","volume":"17","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"6","key":"hep32284-bib-0103-20250824","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jhep.2018.01.031","article-title":"Eight\u2010year survival in chronic hepatitis B patients under long\u2010term entecavir or tenofovir therapy is similar to the general population","volume":"68","year":"2018","journal-title":"J Hepatol"},{"issue":"4","key":"hep32284-bib-0104-20250824","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD\u2010related HCC: trends, predictions, risk factors and prevention","volume":"18","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"hep32284-bib-0105-20250824","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/j.gastro.2020.03.049","article-title":"Risk factors for cirrhosis in contemporary hepatology practices\u2010findings from the Texas Hepatocellular Carcinoma Consortium Cohort","volume":"159","year":"2020","journal-title":"Gastroenterology"},{"issue":"12","key":"hep32284-bib-0106-20250824","doi-asserted-by":"crossref","first-page":"841","DOI":"10.7326\/0003-4819-156-12-201206190-00004","article-title":"Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study","volume":"156","year":"2012","journal-title":"Ann Intern Med"},{"issue":"6","key":"hep32284-bib-0107-20250824","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"hep32284-bib-0108-20250824","doi-asserted-by":"crossref","first-page":"322","DOI":"10.6004\/jnccn.2018.7105","article-title":"Comparative analysis of nonalcoholic steatohepatitis\u2010 versus viral hepatitis\u2010 and alcohol\u2010related liver disease\u2010related hepatocellular carcinoma","volume":"17","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"hep32284-bib-0109-20250824","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","article-title":"Mechanisms of adverse effects of anti\u2010VEGF therapy for cancer","volume":"96","year":"2007","journal-title":"Br J Cancer"},{"issue":"19","key":"hep32284-bib-0110-20250824","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/jama.2021.6238","article-title":"Screening for colorectal cancer: US Preventive Services Task Force recommendation statement","volume":"325","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"hep32284-bib-0111-20250824","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.amepre.2016.04.018","article-title":"Influence of age and comorbidity on colorectal cancer screening in the elderly","volume":"51","year":"2016","journal-title":"Am J Prev Med"},{"issue":"11","key":"hep32284-bib-0112-20250824","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/j.1572-0241.2007.01395.x","article-title":"Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate\/advanced cirrhosis?","volume":"102","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"hep32284-bib-0113-20250824","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00595-014-0994-1","article-title":"Hepatic resection for hepatocellular carcinoma in super\u2010elderly patients aged 80 years and older in the first decade of the 21st century","volume":"45","year":"2015","journal-title":"Surg Today"},{"issue":"3","key":"hep32284-bib-0114-20250824","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jamcollsurg.2013.12.001","article-title":"Increasing age and survival after orthotopic liver transplantation for patients with hepatocellular cancer","volume":"218","year":"2014","journal-title":"J Am Coll Surg"},{"issue":"13","key":"hep32284-bib-0115-20250824","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/hepr.12308","article-title":"Efficacy and safety of sorafenib in very elderly patients aged 80 years and older with advanced hepatocellular carcinoma","volume":"44","year":"2014","journal-title":"Hepatol Res"},{"issue":"8","key":"hep32284-bib-0116-20250824","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7150\/jca.7279","article-title":"Treatment for hepatocellular carcinoma in elderly patients: a literature review","volume":"4","year":"2013","journal-title":"J Cancer"},{"issue":"1","key":"hep32284-bib-0117-20250824","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27598","article-title":"The clinical course of cirrhosis: the importance of multistate models and competing risks analysis","volume":"62","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"hep32284-bib-0118-20250824","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","article-title":"Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta\u2010analysis","volume":"154","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"hep32284-bib-0119-20250824","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/apt.13841","article-title":"Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis","volume":"45","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"hep32284-bib-0120-20250824","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/apt.12370","article-title":"Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography \u2013 a randomised study","volume":"38","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"hep32284-bib-0121-20250824","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/cld.1066","article-title":"Imaging and biomarker approaches to HCC surveillance","volume":"17","year":"2021","journal-title":"Clin Liv Dis"},{"issue":"12","key":"hep32284-bib-0122-20250824","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1158\/1055-9965.EPI-20-0005","article-title":"Biomarkers for the early detection of hepatocellular carcinoma","volume":"29","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"hep32284-bib-0123-20250824","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.cgh.2018.12.005","article-title":"Validation of the hepatocellular carcinoma early detection screening (HES) algorithm in a cohort of veterans with cirrhosis","volume":"17","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"hep32284-bib-0124-20250824","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1053\/j.gastro.2021.01.233","article-title":"International Liver Cancer Association (ILCA) white paper on biomarker development for hepatocellular carcinoma","volume":"160","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"hep32284-bib-0125-20250824","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","article-title":"\u03b1\u2010Fetoprotein, Des\u2010\u03b3 carboxyprothrombin, and lectin\u2010bound \u03b1\u2010fetoprotein in early hepatocellular carcinoma","volume":"137","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"hep32284-bib-0126-20250824","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cgh.2021.08.010","article-title":"Validation of a novel multitarget blood test shows high sensitivity to detect early stage hepatocellular carcinoma","volume":"20","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"hep32284-bib-0127-20250824","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cgh.2015.12.042","article-title":"Role of the GALAD and BALAD\u20102 serologic models in diagnosis of hepatocellular carcinoma and prediction of survival in patients","volume":"14","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep32284-bib-0128-20250824","article-title":"Doylestown plus and GALAD demonstrate high sensitivity for HCC detection in patients with cirrhosis","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"hep32284-bib-0129-20250824","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cgh.2019.11.012","article-title":"GALAD score detects early hepatocellular carcinoma in an international cohort of patients with nonalcoholic steatohepatitis","volume":"18","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep32284-bib-0130-20250824","article-title":"GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis","year":"2021","journal-title":"Hepatology"},{"issue":"9","key":"hep32284-bib-0131-20250824","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1872-034X.2012.01004.x","article-title":"Prediction of recurrence of hepatocellular carcinoma after curative hepatectomy using preoperative Lens culinaris agglutinin\u2010reactive fraction of alpha\u2010fetoprotein","volume":"42","year":"2012","journal-title":"Hepatol Res"},{"issue":"4","key":"hep32284-bib-0132-20250824","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1440-1746.2010.06532.x","article-title":"Lens culinaris agglutinin\u2010reactive fraction of AFP is a useful prognostic biomarker for survival after repeat hepatic resection for HCC","volume":"26","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"hep32284-bib-0133-20250824","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jhep.2016.10.038","article-title":"Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis\u2010related cirrhosis who had received a liver transplant for HCC","volume":"66","year":"2017","journal-title":"J Hepatol"},{"issue":"3","key":"hep32284-bib-0134-20250824","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/hep.30413","article-title":"Alpha\u2010fetoprotein decrease from > 1,000 to < 500 ng\/mL in patients with hepatocellular carcinoma leads to improved posttransplant outcomes","volume":"69","year":"2019","journal-title":"Hepatology"},{"issue":"8","key":"hep32284-bib-0135-20250824","article-title":"Clinical correlates of circulating cell\u2010free DNA tumor fraction","volume":"16","year":"2021","journal-title":"PLoS One"},{"issue":"2","key":"hep32284-bib-0136-20250824","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jhep.2010.03.010","article-title":"Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival","volume":"53","year":"2010","journal-title":"J Hepatol"},{"issue":"6","key":"hep32284-bib-0137-20250824","first-page":"1987","article-title":"Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3\u2010 and 6\u2010month periodicities","volume":"54","year":"2011","journal-title":"Hepatology"},{"key":"hep32284-bib-0138-20250824","article-title":"Overdiagnosis: epidemiologic concepts and estimation","volume":"37","year":"2015","journal-title":"Epidemiol Health"},{"key":"hep32284-bib-0139-20250824","article-title":"Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods","volume":"350","year":"2015","journal-title":"BMJ"},{"key":"hep32284-bib-0140-20250824","article-title":"Quantifying overdiagnosis in cancer screening: a systematic review to evaluate the methodology","volume":"109","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"hep32284-bib-0141-20250824","first-page":"202","article-title":"Overdiagnosis and overtreatment of breast cancer: microsimulation modelling estimates based on observed screen and clinical data","volume":"8","year":"2006","journal-title":"Breast Cancer Res"},{"issue":"21","key":"hep32284-bib-0142-20250824","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","article-title":"Effect of three decades of screening mammography on breast\u2010cancer incidence","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"hep32284-bib-0143-20250824","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ijc.28052","article-title":"Overdiagnosis among women attending a population\u2010based mammography screening program","volume":"133","year":"2013","journal-title":"Int J Cancer"},{"issue":"1","key":"hep32284-bib-0144-20250824","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1472-6874-9-36","article-title":"Overdiagnosis in organised mammography screening in Denmark. A comparative study","volume":"9","year":"2009","journal-title":"BMC Womens Health"},{"issue":"3","key":"hep32284-bib-0145-20250824","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejca.2004.09.030","article-title":"Determining overdiagnosis by screening with DRE\/TRUS or PSA (Florence pilot studies, 1991\u20131994)","volume":"41","year":"2005","journal-title":"Eur J Cancer"},{"issue":"1","key":"hep32284-bib-0146-20250824","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.30129","article-title":"Mailed outreach invitations significantly improve HCC surveillance rates in patients with cirrhosis: a randomized clinical trial","volume":"69","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"hep32284-bib-0147-20250824","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.31309","article-title":"Use of hepatocellular carcinoma surveillance in patients with cirrhosis: a systematic review and meta\u2010analysis","volume":"73","year":"2021","journal-title":"Hepatology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.32284","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.32284","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.32284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:03:36Z","timestamp":1756080216000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.32284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":147,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.32284","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,18]]},"assertion":[{"value":"2021-11-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}